Intrinsic Factor: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Intrinsic Factor. Educational only — not medical advice.
Labeled uses
BioparTM delta -FORTE is specifically indicated as a primary and adjunctive treatment in pernicious anemia patients having idiosyncrasy or sensitivity to parenteral administration - or when parental therapy is refused;
Source: FDA labeling via NIH DailyMed (set ce7d1f45…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.